Upon its ligand CCL19 stimulation, CCR7 is activated, resulting in phosphorylation of MAPK members (ERK1/2 and JNK) to promote cell migration and invasion in head and neck carcinoma [36]. Here, MAPK3 is linked to head and neck carcinoma.